The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Mar. 02, 2021
Filed:
Feb. 13, 2015
Applicant:
Bellicum Pharmaceuticals, Inc., Houston, TX (US);
Inventors:
Aaron Edward Foster, Houston, TX (US);
David Spencer, Houston, TX (US);
Matthew Robert Collinson-Pautz, Houston, TX (US);
Kevin Slawin, Houston, TX (US);
Assignee:
Bellicum Pharmaceuticals, Inc., Houston, TX (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 14/705 (2006.01); C07K 16/18 (2006.01); A61K 35/14 (2015.01); C07K 14/00 (2006.01); C07K 14/47 (2006.01); A61K 38/00 (2006.01);
U.S. Cl.
CPC ...
C07K 16/18 (2013.01); A61K 35/14 (2013.01); C07K 14/00 (2013.01); C07K 14/4705 (2013.01); C07K 14/70578 (2013.01); A61K 38/00 (2013.01); C07K 2317/622 (2013.01); C07K 2319/30 (2013.01); C07K 2319/33 (2013.01); Y02A 50/30 (2018.01);
Abstract
The technology relates generally to the field of immunology and relates in part to methods for activating cells, including for example T cells and T cells that express chimeric antigen receptors, using an inducible chimeric polypeptide including CD40, MyD88, or CD40 and MyD88 polypeptides. The technology further relates in part to therapeutic methods for inducing an immune response and treating tumors in a patient.